Inactive Instrument

Johnson & Johnson Share Price Buenos Aires S.E.

Equities

DJNJ3D

ARDEUT112687

Pharmaceuticals

Financials

Sales 2024 * 88.35B 78,984B 6,921B Sales 2025 * 90.76B 81,141B 7,110B Capitalization 354B 316,216B 27,708B
Net income 2024 * 22.04B 19,703B 1,726B Net income 2025 * 23.09B 20,644B 1,809B EV / Sales 2024 * 3.92 x
Net cash position 2024 * 7B 6,255B 548B Net cash position 2025 * 19.84B 17,739B 1,554B EV / Sales 2025 * 3.68 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
15.4 x
Employees 131,900
Yield 2024 *
3.28%
Yield 2025 *
3.43%
Free-Float 77.08%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 61 31/12/88
Director of Finance/CFO 57 31/12/97
Chief Tech/Sci/R&D Officer 58 04/11/19
Members of the board TitleAgeSince
Director/Board Member 70 24/04/19
Director/Board Member 72 18/06/14
Director/Board Member 70 21/10/09
More insiders
Date Price Change Volume
27/05/24 1,250 -.--% 9
23/05/24 1,250 -.--% 11

End-of-day quote Buenos Aires S.E., April 25, 2024

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company